Page last updated: 2024-08-21

dronabinol and Leukemia, Lymphocytic

dronabinol has been researched along with Leukemia, Lymphocytic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fisher, M; Grant, S; Lombard, C; Martin, BR; McKallip, RJ; Nagarkatti, M; Nagarkatti, PS; Ryu, S	1

Other Studies

1 other study(ies) available for dronabinol and Leukemia, Lymphocytic

Article	Year
Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Blood, 2002, Jul-15, Volume: 100, Issue:2 Topics: Animals; Antineoplastic Agents; Apoptosis; Cannabinoids; Cell Survival; Dose-Response Relationship, Drug; Dronabinol; Drug Evaluation, Preclinical; Humans; Leukemia, Lymphoid; Ligands; Mice; Mice, Inbred C57BL; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptors, Cannabinoid; Receptors, Drug; Survival Rate; Treatment Outcome; Tumor Cells, Cultured	2002

Article

Year

Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease.

Blood, 2002, Jul-15, Volume: 100, Issue:2

Topics: Animals; Antineoplastic Agents; Apoptosis; Cannabinoids; Cell Survival; Dose-Response Relationship, Drug; Dronabinol; Drug Evaluation, Preclinical; Humans; Leukemia, Lymphoid; Ligands; Mice; Mice, Inbred C57BL; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptors, Cannabinoid; Receptors, Drug; Survival Rate; Treatment Outcome; Tumor Cells, Cultured

2002